- Home
- MRT vs NERV Comparison
MRT vs NERV Comparison
Compare MRT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRT | NERV |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | Turkey | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.4M | 166.4M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MRT | NERV |
|---|---|---|
| Price | $1.80 | $2.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $5.04 | ★ $10.33 |
| AVG Volume (30 Days) | 44.8K | ★ 137.0K |
| Earning Date | 08-08-2018 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,175,600.00 |
| Revenue This Year | $116.52 | N/A |
| Revenue Next Year | $59.73 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.12 | $2.39 |
| 52 Week High | $2.75 | $12.46 |
Technical Indicators
Market Signals| Indicator | MRT | NERV |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 22.36 |
| Support Level | $1.63 | N/A |
| Resistance Level | $1.87 | $4.73 |
| Average True Range (ATR) | 0.11 | 0.25 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 5.66 | 2.26 |
Price Performance
Historical ComparisonAbout MRT Marti Technologies Inc.
Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.